Neurorehabilitation Devices Market is expected to reach US$ 7,086.82 Million by 2031

Brain Computer Interface Segment to Lead Neurorehabilitation Devices Market Based on Product Type During 2023–2031

According to our new research study on "Neurorehabilitation Devices Market Forecast to 2031 – Global Analysis – by Product Type, Application, and End User," the market was valued at US$ 2,725.76 million in 2023 and is projected to reach US$ 7,086.82 million by 2031; it is expected to register a CAGR of 12.7% from 2023 to 2031. Major factors driving the market include the rising prevalence of neurological diseases worldwide and the growing number of clinical studies on neurorehabilitation devices. However, the high cost of neurorehabilitation devices hinders market growth. Technological advancements in neurorehabilitation devices are projected to bring new neurorehabilitation devices market trends in the coming years.

Neurorehabilitation devices are specialized tools and technologies designed to assist in the recovery and rehabilitation of individuals with neurological disorders, such as stroke, traumatic brain injury, spinal cord injuries, and neurodegenerative diseases. These devices enable physical, cognitive, and functional rehabilitation by providing targeted therapies and exercises. Types of neurorehabilitation devices include robotic exoskeletons, functional electrical stimulation, virtual reality (VR) systems, and brain computer interfaces. These devices are essential in helping patients regain independence and improve their quality of life through personalized rehabilitation programs. Additionally, advanced technologies such as neuromodulation techniques have shown promise in improving rehabilitation outcomes by stimulating brain areas involved in recovery. The greater awareness of the benefits of early, personalized rehabilitation therapies and the aging population are contributing to the growing neurorehabilitation devices market size. Furthermore, innovations in personalized therapy and telerehabilitation solutions are expanding access and efficiency, boosting the neurorehabilitation devices market for significant expansion in the coming years.

Neurorehabilitation Devices Market, by Region, 2023 (%)

Source: The Insight Partners Analysis

Neurorehabilitation Devices Market Analysis Based on Segmental Evaluation:

Based on product type, the neurorehabilitation devices market is categorized into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. In 2023, the brain computer interface segment held a significant neurorehabilitation devices market share, and it is expected to register the highest CAGR in the market during 2023–2031. Brain computer interface is combined with other techniques, such as VR and functional electrical stimulation, to help patients restore neurological functioning. These significant innovations in neurorehabilitation allow direct communication between the brain and external devices. Technological advancements and increased use of advanced technologies, such as machine learning, virtual reality, and artificial intelligence, have created the demand for brain computer interfaces. This technology is being explored extensively for stroke rehabilitation, where it can help patients regain motor functions by facilitating brain plasticity and retraining motor pathways. The increased application of brain computer interface in the field of neurorehabilitation has increased strategic initiatives such as collaborations, product approvals, and product launches. For instance, in November 2023, Neurolutions, Inc. and Kandu Health collaborated to increase access to breakthrough brain computer interface and remote support for stroke rehabilitation. This also helps in promoting the standard of care for post-stroke recovery. In April 2021, Neurolutions Inc. – a Washington University in St. Louis-based startup company focused on brain computer interface, developed the IpsiHand Upper Extremity Rehabilitation System, and it has received market authorization from the Food and Drug Administration (FDA).

The scope of the neurorehabilitation devices market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the neurorehabilitation devices market share in 2023. The high prevalence of neurological disorders—particularly among the aging population, which significantly increases the demand for effective rehabilitation solutions—and supportive government policies and funding initiatives are a few of the key factors propelling the neurorehabilitation devices market growth in North America. In addition, the new product launches and increase in research and development for developing advanced devices favor the market growth in the region. The US is one of the most developed countries in North America. The country accounts for the major market share owing to the surging prevalence of neurological disorders, followed by technological advancements in the field of neurorehabilitation devices. A large portion of the US population suffers from neurological conditions such as multiple sclerosis and cerebral palsy. According to the Birth Injury Justice Center, cerebral palsy is the most common physical disability in childhood, affecting 1 million people in the US.

An increasing number of neuro rehab centers equipped with advanced technologies is expected to support the neurorehabilitation devices market growth during the forecast period. For instance, in June 2024, Neurofenix launched a virtual clinic for home-based Neuro Rehab in Florida to help patients perform varied exercises aimed at improving motor skills and functional ability, all from the comfort of their homes. In addition, in October 2020, Neuro Rehab VR released its XR Therapy System, a clinically validated and FDA-registered virtual reality (VR) therapy system for neurological rehabilitation and physical therapy treatment and assessment in clinical environments.

Additionally, the Canada neurorehabilitation devices market is driven by the increasing cases of stroke, traumatic brain injury, and disabilities caused by related conditions. The increase in product approvals and product launches in the country is expected to support market growth. In May 2023, Alberta Health Services and the University of Calgary partnered to assist people suffering from strokes, spinal cord injuries, and movement issues. This partnership helps ensure the continuity of care and access to innovative neurorehabilitation techniques for individuals of all ages. Mexico is expected to experience significant development in healthcare facilities and infrastructure owing to a rise in healthcare expenditure. The country is experiencing a surge in the incidence of neurological disorders and disabilities. According to the MS International Federation 2024 report, in Mexico, 18,000 people suffer from multiple sclerosis. Additionally, in 2022, in Mexico, there were 1,111 million women with disabilities, representing 53% of the total number of people with disabilities. The surging prevalence of neurological disorders and disabilities is anticipated to create vital growth opportunities for the players in the market in Mexico.

Blackrock Microsystems Inc, Hocoma AG, Medtronic Plc, Tyromotion GmbH, Ekso Bionics Holdings Inc, BIONIK, Abbott Laboratories, Renishaw Plc, EMOTIV, and BioXtreme Ltd. are among the leading companies profiled in the neurorehabilitation devices market report.

Based on product type, the neurorehabilitation devices market is categorized into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. Based on application, the market is divided into stroke, spinal cord injury, cerebral palsy, traumatic brain injury, Parkinson's disease, and others. By end user, the neurorehabilitation devices market is segmented into hospitals and clinics, rehabilitation centers, and home care. Geographically, the market is categorized into North America (US, Canada and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com